Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1995 Dec;74(6):584–591. doi: 10.1136/hrt.74.6.584

Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.

E Arbustini 1, M Grasso 1, R Fasani 1, C Klersy 1, M Diegoli 1, E Porcu 1, N Banchieri 1, P Fortina 1, C Danesino 1, G Specchia 1
PMCID: PMC484110  PMID: 8541160

Abstract

OBJECTIVE--To investigate the association of the three angiotensin converting enzyme (ACE) genotypes, DD, ID, and II, with the occurrence or absence of coronary atherosclerosis and with myocardial infarction and hypertension. DESIGN--Cohort analysis study. SETTING--North-Italy reference centre. SUBJECTS--388 white Italian patients (281 males; mean age 60.7 (SD 12.5) years) with proven coronary atherosclerosis (n = 255) or with angiographically normal coronary arteries (n = 133). A further group of 290 healthy blood donors was tested for allele frequency comparison. INTERVENTIONS--ACE/ID polymorphism was analysed with polymerase chain reaction on DNA from white blood cells. MAIN OUTCOME MEASURES--Coronary atherosclerosis, myocardial infarction, hypertension. RESULTS--The D and I allele frequencies were respectively 0.63 and 0.37 in the overall healthy blood donor group and 0.66 and 0.34 in the overall study group. In the latter, univariate analysis showed (1) that coronary atherosclerosis (255 patients) was associated with the deletion allele, with an odds ratio (OR) of 5.78 for DD/II, P < 0.001, and 2.39 for ID/II, P = 0.006; and (2) that myocardial infarction (154 patients) was associated with the DD genotype (OR DD/II = 2.56, P = 0.007), but not with the ID genotype (OR DD/II = 1.96, P = 0.056). Finally, hypertension proved to be unrelated with the ACE genotype. The distribution between the three genotypes of known risk factors for coronary artery disease was similar. Logistic regression modelling, performed to test the association of the selected risk factors simultaneously with coronary atherosclerosis and myocardial infarction, showed that the deletion allele (whether DD or ID) was the strongest risk factor for atherosclerosis, and that the D allele was significantly associated with the risk of infarction (although to a lesser extent than with coronary atherosclerosis). CONCLUSION--ACE deletion polymorphism is strongly and independently associated with coronary atherosclerosis and, to a lesser extent, with myocardial infarction. As such, the results are analogous to what has already been reported in French white, Japanese, and Welsh coronary patients.

Full text

PDF
584

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alhenc-Gelas F., Richard J., Courbon D., Warnet J. M., Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991 Jan;117(1):33–39. [PubMed] [Google Scholar]
  2. Arbustini E., De Servi S., Bramucci E., Porcu E., Costante A. M., Grasso M., Diegoli M., Fasani R., Morbini P., Angoli L. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. Am J Cardiol. 1995 Apr 1;75(10):675–682. doi: 10.1016/s0002-9149(99)80652-3. [DOI] [PubMed] [Google Scholar]
  3. Arbustini E., Grasso M., Diegoli M., Morbini P., Aguzzi A., Fasani R., Specchia G. Coronary thrombosis in non-cardiac death. Coron Artery Dis. 1993 Sep;4(9):751–759. doi: 10.1097/00019501-199309000-00001. [DOI] [PubMed] [Google Scholar]
  4. Benedetti J. K., Brown M. B. Strategies for the selection of log-linear models. Biometrics. 1978 Dec;34(4):680–686. [PubMed] [Google Scholar]
  5. Betriu A., Castañer A., Sanz G. A., Pare J. C., Roig E., Coll S., Magriña J., Navarro-Lopez F. Angiographic findings 1 month after myocardial infarction: a prospective study of 259 survivors. Circulation. 1982 Jun;65(6):1099–1105. doi: 10.1161/01.cir.65.6.1099. [DOI] [PubMed] [Google Scholar]
  6. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  7. Costerousse O., Allegrini J., Lopez M., Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993 Feb 15;290(Pt 1):33–40. doi: 10.1042/bj2900033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dux S., Aron N., Boner G., Carmel A., Yaron A., Rosenfeld J. B. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Isr J Med Sci. 1984 Dec;20(12):1138–1142. [PubMed] [Google Scholar]
  9. Friedlander Y., Kark J. D., Stein Y. Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J. 1985 Apr;53(4):382–387. doi: 10.1136/hrt.53.4.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Higashimori K., Zhao Y., Higaki J., Kamitani A., Katsuya T., Nakura J., Miki T., Mikami H., Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993 Mar 15;191(2):399–404. doi: 10.1006/bbrc.1993.1231. [DOI] [PubMed] [Google Scholar]
  11. Homcy C. J., Liberthson R. R., Fallon J. T., Gross S., Miller L. M. Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol. 1982 Feb 1;49(2):478–484. doi: 10.1016/0002-9149(82)90528-8. [DOI] [PubMed] [Google Scholar]
  12. Islim I. F., Beevers D. G., Bareford D. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension. J Hypertens. 1992 Apr;10(4):379–383. doi: 10.1097/00004872-199204000-00010. [DOI] [PubMed] [Google Scholar]
  13. Jeunemaitre X., Lifton R. P., Hunt S. C., Williams R. R., Lalouel J. M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992 Apr;1(1):72–75. doi: 10.1038/ng0492-72. [DOI] [PubMed] [Google Scholar]
  14. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 Oct 2;71(1):169–180. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  15. Kannel W. B., Abbott R. D. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984 Nov 1;311(18):1144–1147. doi: 10.1056/NEJM198411013111802. [DOI] [PubMed] [Google Scholar]
  16. Lee E. J. Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol. 1994 Feb;37(2):212–214. doi: 10.1111/j.1365-2125.1994.tb04264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., LaMotte F., Buring J., Hennekens C. H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995 Mar 16;332(11):706–711. doi: 10.1056/NEJM199503163321103. [DOI] [PubMed] [Google Scholar]
  18. Ludwig E., Corneli P. S., Anderson J. L., Marshall H. W., Lalouel J. M., Ward R. H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995 Apr 15;91(8):2120–2124. doi: 10.1161/01.cir.91.8.2120. [DOI] [PubMed] [Google Scholar]
  19. MILLER R. D., BURCHELL H. B., EDWARDS J. E. Myocardial infarction with and without acute coronary occlusion; a pathologic study. AMA Arch Intern Med. 1951 Nov;88(5):597–604. doi: 10.1001/archinte.1951.03810110049005. [DOI] [PubMed] [Google Scholar]
  20. Mattu R. K., Needham E. W., Galton D. J., Frangos E., Clark A. J., Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995 Jan 15;91(2):270–274. doi: 10.1161/01.cir.91.2.270. [DOI] [PubMed] [Google Scholar]
  21. Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994 Nov;90(5):2199–2202. doi: 10.1161/01.cir.90.5.2199. [DOI] [PubMed] [Google Scholar]
  22. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  23. Raynolds M. V., Bristow M. R., Bush E. W., Abraham W. T., Lowes B. D., Zisman L. S., Taft C. S., Perryman M. B. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993 Oct 30;342(8879):1073–1075. doi: 10.1016/0140-6736(93)92061-w. [DOI] [PubMed] [Google Scholar]
  24. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruiz J., Blanché H., Cohen N., Velho G., Cambien F., Cohen D., Passa P., Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3662–3665. doi: 10.1073/pnas.91.9.3662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  27. Sones F. M., Jr Indications and value of coronary arteriography. Circulation. 1972 Dec;46(6):1155–1160. doi: 10.1161/01.cir.46.6.1155. [DOI] [PubMed] [Google Scholar]
  28. Spodick D. H. Inflammation and the onset of myocardial infarction. Ann Intern Med. 1985 May;102(5):699–702. doi: 10.7326/0003-4819-102-5-699. [DOI] [PubMed] [Google Scholar]
  29. Tiret L., Kee F., Poirier O., Nicaud V., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Amouyel P. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993 Apr 17;341(8851):991–992. doi: 10.1016/0140-6736(93)91075-w. [DOI] [PubMed] [Google Scholar]
  30. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992 Jul;51(1):197–205. [PMC free article] [PubMed] [Google Scholar]
  31. Wei J. Y., Bulkley B. H. Myocardial infarction before age 36 years in women: predominance of apparent nonatherosclerotic events. Am Heart J. 1982 Sep;104(3):561–566. doi: 10.1016/0002-8703(82)90227-7. [DOI] [PubMed] [Google Scholar]
  32. van der Wal A. C., Das P. K., Bentz van de Berg D., van der Loos C. M., Becker A. E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 1989 Aug;61(2):166–170. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES